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Whilst Antimicrobial Stewardship (AMS) is being implemented in different countries, different 
contexts continue to present unique challenges. We investigated the challenges to implementing 
AMS in different countries by examining comments from clinical, academic, and lay learners 
participating in a Massive Open Online Course (MOOC) on tackling antimicrobial resistance (AMR).  
Methods 
A 3-week MOOC titled “Tackling AMR: A social science approach” was developed with a global 
faculty in collaboration with the British Society of Antimicrobial Chemotherapy and Imperial College 
London and launched in November 2019. Learners were asked specific questions about their 
experiences of AMS throughout the MOOC which included 38 optional free text prompts. Learners' 
free text responses from first three-course runs (November 2019 – July 2020) were collated and 
coded in NVivo 12 using a conventional content analysis approach to identify challenges to 
implementing AMS across countries.  
Results 
Representing 114 countries, 1464 learners enrolled, with largest representation from the United 
Kingdom, India, Nigeria, Australia, and Pakistan. The learners described a range of AMS activities and 
team compositions. While recognising the importance of pharmacist and nurse roles in AMS, the 
learners reported that such roles remain ill-defined across countries, restricting the reach and 
potential of AMS strategies. A range of challenges to implementing AMS were described, including: 
limited awareness and engagement by the general public and healthcare workers (HCW) on the 
impact of AMR on human health, lack of adequate of governance and policy; inconsistencies in 
surveillance for antibiotic consumption and AMR, impeding feedback loops and improvement 
processes; human resource and technological constraints; variable access to key antibiotics; lack of 
ownership of antibiotic decision-making and buy-in from different clinical specialties. Patients’ 
knowledge, experiences and perspectives were recognised as a valuable source of information that 
needed to be incorporated in AMS initiatives to overcome cultural barriers to the judicious use of 
antibiotics.  
Conclusion 
Analysis of learner comments and reflections identified a range of enablers and barriers to AMS 
implementation across different healthcare economies. Common challenges to AMS implementation 
included the role of non-physician health care professionals, resources, knowledge of AMR and 









Antimicrobial resistance (AMR) is a silent pandemic that requires urgent multisectoral action.(1) The 
WHO endorsed Global Action Plan on AMR provides guidance for countries to develop strategies to 
tackle AMR, including implementing antimicrobial stewardship (AMS) programmes. Individual 
countries are at different stages of implementing national action plans across sectors, driven 
amongst other things by existing capacity, resource limitations and political drivers.(2,3) Effective 
AMS is a multimodal and interdisciplinary approach to changing behaviours and aims to optimise 
antibiotic use and preserving their efficacy.(4)(5) Whilst most evidence continues to be generated 
from high-income countries (6) increasingly positive outcomes associated with AMS are being 
reported from low- and middle-income countries (LMICs).(7–9)  
To effectively optimise antibiotic use, AMS should be implemented across primary, secondary, and 
tertiary sectors. Multidisciplinarity in AMS teams is important (5) as is leadership, and effective 
mechanisms for surveillance, access to policies and guidelines, and education and training for AMS 
teams as well as for other healthcare workers (HCWs).(10,11) Whilst guidelines, policies and global 
and national action plans exist, significant differences remain in AMS strategies, including 
differences in team composition, and in indicators used to measure success.(7,12–14) To facilitate  
effective implementation, contextualized strategies are needed.(9) The range of reported barriers to 
AMS include: diagnostic challenges; varied knowledge and awareness on optimal antibiotic use; 
access to antibiotics; healthcare facilities varying in infrastructure and patient numbers; inadequacy 
of information systems; lack of key personnel and funding, and the competing healthcare needs of 
populations which drive prioritisation of initiatives.(9,15) In many countries, AMS is led by doctors 
with little input from healthcare professionals like pharmacists and nurses, despite their potential for 
active roles in AMS. Furthermore, AMS initiatives rarely involve patients.(16) 
 
Antibiotic prescribing, is a complex, social process reliant on different people and influenced by 
determinants such as the opinions of peers and hierarchies that exist within clinical teams.(17) In the 
last ten years a growing body of literature applying social science approaches has provided insights 
the impact of behaviour and social norms on antibiotic prescribing in different contexts, recognising 
that antibiotic prescribing is a social process.(18–20) Effective use of theories, frameworks, and 
methods from behavioural and psychological sciences however, remain inaccessible to most AMS 
practitioners.(21) Harnessing the growing body of qualitative literature on this topic, we brought 
together key research expertise from across social sciences, implementation science, infectious 
diseases (ID), and patient and public advocacy to develop a 3-week long Massive Open Online 
Course (MOOC) titled “Tackling AMR: A social science approach” to make such approaches more 
accessible to AMS practitioners. This introductory course focussed on the practical and real-world 
application of social science methods using examples of clinical practice and research from high-
income countries and LMICs.  
 
MOOCs have been gaining popularity to provide education to a wider audience.(22,23) In this article, 
we describe how use of a MOOC platform provided an opportunity to gather diverse narratives from 
around the world on AMS in a large number of contexts and experience of developing and 
implementing AMS. These narratives also gave us fresh insights into the unique challenges that 




The e-learning initiative was funded by the Economic and Social Research Council (ESRC) with the 
aim to enhance the impact of existing ESRC-funded research to a wider global audience, including 




of social science methodologies to tackle AMR, the content was specifically developed to address 
this gap. The content was designed to complement the existing World Health Organisation and 
British Society for Antimicrobial Chemotherapy (BSAC) e-learning initiatives.(23) Drawing on from 
state-of-the-art evidence from application of social science research to tackling AMR across different 
countries, the international faculty represented expertise across social sciences, ID, implementation 
science, pharmacy, patient and public advocacy and nursing, general practice and knowledge 
mobilisation.  
 
The open access course, hosted on an established platform with wide global reach, linked to existing 
BSAC MOOCs and targeted healthcare professionals, researchers, and students. It was designed as 
an interactive module that uses a range of techniques such as video case presentations interspersed 
with knowledge tests to enhance participant engagement and learning. Each week had two hours of 
materials which the learners could finish at their own pace. Week one of the course included in 
depth discussions on structure, functioning and challenges faced by AMS from experts across high- 
income countries and LMICs. Week two introduced how social science methodologies can be used to 
study AMR and included practical sessions by researchers from different parts of the world. Week 
three introduced the learners to implementation science and discussed the role played by patients 
and public in AMR. At the end of each subsection, learners were asked specific questions about AMS 
in their country including 38 optional free text prompts. Throughout the course, learners were 
encouraged/prompted to share their experiences and to ask topic specific questions. The lead 
educators of the course periodically responded to comments and queries from the learners. 
 
Basic learner demographic data including country, age and occupation were collected from Future 
Learn database. Learners’ free text responses from the three course runs were collated and coded in 
NVivo 12 using a conventional content analysis approach by four researchers. These codes were 
analysed by the researchers to identify the composition and challenges to AMS. The purpose of this 
paper is to provide a summary of responses and not to compare the perspectives between learners 
and across countries.  
 
Results   
 
General characteristics of learners 
Between November 2019 and July 2020, 1464 learners joined the MOOC. Of the learners who 
indicated their ages, the largest proportion (443/1464, 30.2%) were in the 26-35 age category. There 
were 754/1464 (51.5%) learners from high-income countries, 646/1464 (44.1%) from LMICs, and 
64/1464 (4.4%) did not register their country. Out of the total learners, 601/1464 (41%) marked at 
least one step as complete (active learners) and 199/1464 (14%) posted at least one comment on 
any step of the course (social learners). Marking steps as complete is an optional step in the MOOC, 
and learners could have completed the entire course without marking any step as complete. Data on 
which countries these social learners were from was unavailable. These social learners included 
healthcare professionals primarily doctors, pharmacists, and nurses; students, mainly medical, 
nursing and pharmacy; and researchers. The analysis of the discourse that was generated through 
the prompts identified key themes that impact AMS delivery: AMS teams composition and activities, 
ill-defined roles for nurses and pharmacists, key challenges to implementing AMS strategies, and 
roles of the patient and the public in AMS. In the following sections we describe the key emerging 
themes from the responses and comments of these learners. Additionally the learners, through their 
own experiences had a series of recommendations for AMS strategies could be improved. We 
present these at the end of the results.  
 




Whilst at least some components of AMS is reported to exist to varying degrees in different 
countries (X1, X2, X3 Table1), some learners reported the absence of stewardship programmes in 
the places where they work (X4, X5, X6 Table 1). Guidelines and policies do exist (X7, X8, X9 Table 1), 
but they are not always put into practice (X10, X11 Table 1). A lack of guidelines (X12, X13 Table 1) 
was also reported by some learners. The composition of AMS teams also varied. Learners described 
a range of AMS activities aimed to support and guide appropriate antibiotic prescribing and use 
through leadership and input to clinical teams as summarised in Box 1. Strategies to engage 
colleagues in AMS vary from scheduled antibiotic discussions in small huddles between doctors and 
nurses to weekly multidisciplinary stewardship rounds with input from ID specialists, infection 
prevention and control (IPC) teams, pharmacist, microbiologists and concerned clinicians (X1, Table 
1). Other strategies reported include academic input meetings; policy development and ongoing face 
to face or in some settings, tele health support by ID specialists and AMS pharmacists (X2, Table 1).  
 
Ill-defined roles for nurses and pharmacists 
A recurring response from learners is that the distinct role of nurses and pharmacists in AMS 
remains ill defined. A summary of general findings on pharmacists and nurses reported roles and 
challenges in AMS across sectors is presented in Table 2. Pharmacists offer a patient-by-patient 
ground level view and hospital-wide perspective on antibiotic use and consumption (X14, Table 1). 
Acting as gatekeepers', pharmacists review and authorise antibiotic prescriptions and provide advice 
on the indication of restricted antibiotics in hospital (X15, X16, Table1). Some learners ascribe the 
lack of training and knowledge on antimicrobial drugs and AMR and the restricted/limited 
perception of the pharmacist's role by colleagues as barriers in their active role and contribution to 
AMS (X17, X18, Table 1). Gatekeeping antibiotic access is far more challenging in primary care where 
self-medication and over the counter sales of antibiotics are authorised. As medicines expert, 
pharmacists are ideal candidates to provide education to healthcare professionals and patients on 
the impact of antibiotic use (X19,20, Table 1).  
The role of nursing in AMS is not clearly defined in policies or guidelines. Even though the nurses’ 
role in AMS is perceived to be limited to antibiotic administration (X18, Table 1), routine nursing 
roles also include monitoring and reporting response to antimicrobial treatment and early signs of 
infection as well as obtaining relevant samples in a timely manner (X21, Table 1). Learners report 
that nurses play an active role educating patients about the use of antibiotics and ensure that 
courses of antimicrobials are completed while in hospital (X19, X22, Table 1).  
 
Challenges to implementing AMS across settings 
Figure 1 depicts a summary of responses from learners on the perceived challenges of implementing 
AMS across different contexts, grouped into team- and systems-based challenges.  
In general, learners perceived that the public and HCWs have limited awareness on the impact of 
AMR on human health (X23, Table 1). The impact of AMR is under prioritized in some settings where 
learners describe a lack of emphasis, awareness, and priority from national, state, and local 
authorities. Discrepancies exist between National Action Plans and actual interventions to combat 
AMR (X24,X25,X26 Table1). While AMS specific policies and protocols are unavailable in some 
countries, where they do exist policies are not always targeted to effectively inform antibiotic 
prescribing across both primary and secondary care (X27, Table 1). AMS support to rural hospitals is 




AMS highlights human resource and capacity challenges while technological constraints include the 
absence of electronic prescription systems (X9, Table 1).  
Whilst unreliable access to antibiotics is a recognised concern, where and when they are available, a 
myriad of other factors impacts on their optimised use. Some learners observe a lack of ownership 
of antibiotic stewardship practices by prescribers and members of their healthcare teams and list 
among others, several behavioural approaches/challenges to antibiotic prescribing that affect 
decision making (X28, Table 1). The gap in the clarity of roles and expectations by other healthcare 
teams of AMS teams, together with how the interface between these two groups is described, 
points towards elements of challenge to AMS which include varied prescribing practices and buy-in 
(X29, X30, Table 1).  
A variability of surveillance and AMR is reported by learners. Surveillance data on antibiotic 
consumption, healthcare associated infections and resistance patterns to inform or improve 
infection management practices are infrequent, poorly captured, or absent (X31, X32, Table 1). 
These inconsistencies are further challenged by limited/ inadequate or absent audit and feedback 
loops to improve processes. While there are many serious short- and long-term repercussions on 
patient outcomes and AMR resulting from sub-optimal surveillance, learners also highlight the 
hidden financial implications of infections due to the absence of economic data and analysis (X33, 
Table 1). 
The role of patients and the public in AMS and the wider AMR landscape  
 
Learners acknowledged that patients have a key role to play in AMS as they are the consumers of 
antibiotics and beneficiaries of health services (X34, Table 1). As the main source of continuity, a 
patient’s perspective can provide invaluable insight into past treatment plans and contribute 
knowledge that can potentially enhance the success of future treatment options identified by the 
clinician (X35, Table 1). There is also a need to explore how much patients understand their own 
care needs so that health communication can be tailored to their needs (X36, Table 1). As well as 
involving patients in their care, patient involvement in the wider development and evaluation of 
interventions is essential as it will highlight needs that health care professionals haven't considered 
(e.g. communication, risks, etc) (X37, Table 1). With unregulated access to antibiotics a concern in 
many countries, learners suggest that education on the adverse effects of the unnecessary use of 
antibiotics should be provided to patients to tackle AMR (X38, Table 1).  
 
Recommendations for Improvement  
Learners have put forth various recommendations for how antimicrobial prescribing and AMS can be 
improved. Box 3 summarises these recommendations.  
Discussion 
In this article we analysed responses from learners around the world who enrolled in a 3-week long 
Massive Open Online Courses (MOOC) on applying social science methods to tackle antimicrobial 
resistance (AMR). The reponses yielded rich data on the unique challenges and experiences of 
developing and implementing AMS across different countries. The reported challenges to 
implementing AMS strategies include: limited awareness on the impact of AMR on human health; 
lack of governance and policy; insufficient surveillance for antibiotic consumption and AMR; human 
resource and technological constraints; variable access to essential antibiotics; lack of ownership of 




experiences and perspectives were recognised as valuable in the consideration of AMS 
initiatives.(24)  
Even though AMS is a universal concept, there is a difference in the way it is implemented in 
different settings as evident from the responses from our learners. Delivering AMS through a 
multidisciplinary team is desirable; however, it may not be feasible in all contexts especially due to 
resource constraints. Pharmacist driven or led AMS programs have shown to improve antimicrobial 
prescriptions where there is a lack of availability of ID specialists.(25,26) While it was recognized by 
the learners that involving pharmacists and nurses in AMS is beneficial, their distinct roles remain ill-
defined in many countries, offering a potential problem in implementation of global AMR priorities. 
Published evidence also suggest that the extent to which these professionals are involved remains to 
be a barrier. (27,28) Patient education on rational antibiotic use was an area that the learners 
acknowledged pharmacist and nurses to have an important role.  
In general, the public and HCWs have limited awareness of the impact of AMR on human health. This 
may be due to many reasons, and may be linked to the ripple of effect of the lack of government 
leadership. In some countries, the impact and effect of AMR are perceived as not being prioritised 
and learners describe a lack of emphasis, awareness, and significance attributed to this from 
national, state, and local authorities. A qualitative study investigating cultural and contextual 
determinants of AMS across different countries found that government or state involvement could 
be both a help or hindrance to effective AMS e.g. in high-income countries, too much interference 
caused conflicting messages and a disruption to AMS,(29) leading to uncoordinated and unfocused 
messages risking ‘AMR-fatigue’. Conversely in LMICs the lack of government support and poor 
infrastructure were considered barriers to AMS. An interesting outcome was that irrespective of 
income status or central governance endorsement, local championing and leadership was 
considered a key facilitator to successful AMS implementation.(29) 
Difficulty in implementing AMS in rural areas is a thread that has been reported in other 
studies.(30)(31) In a mixed methods study to identify barriers and enablers for implementing AMS in 
regional and rural hospitals in Australia, barriers include lack of access to education, resources and 
specialist support.(30) To re-iterate the influence of resource availability on AMS in rural district 
facilities, a situational analysis reviewing existing AMS facilities in a South African province reported 
that AMS was less likely to be established in rural districts with smaller facilities and smaller staff 
complements.(31) Specialist onsite support which includes ID, clinical microbiology and pharmacy 
(30,32,33) is deemed key to success for the development of AMS programs but may not be feasible 
or possible in many settings. However outcomes from pharmacists-led interventions conducted in 
several countries in Africa have demonstrated improvements including in better hang-time 
compliance and a reduction in surgical site infections, and antibiotic use, demonstrating that AMS 
can be implemented with limited specialist resources and extended to remote areas. (26,34,35) 
Whilst a multidisciplinary AMS team remains the gold standard, existing evidence suggests having 
the right person lead the AMS programme may be sufficient to making a measurable difference. 
 
The influence of the health-care system, availability of antibiotics and diagnostic capability; and IPC 
practices on AMS interventions is well described, where the discrepancies between income status is 
often highlighted.(6,9,36) However, when considering antibiotic decision making, associated 
behaviours linked with prescribing practices seem universal and less linked to the country’s income 
status.(17–19,37) Rather, prescribing practices are influenced by cultural and contextual boundaries 
and practices.(4) Learners further highlight challenges in stewardship emphasising gaps between 




including that AMS teams can work in isolation often with limited engagement with other specialties 
(4,38); roles and expectations in AMS from the wider multidisciplinary team are unclear(18,19,37); 
lack of buy-in from clinicians from various departments in AMS.(37) 
Surveillance data on antibiotic consumption, HAI and resistance patterns to inform or improve 
prescribing and clinical outcomes are infrequent, poorly captured, or absent. The benefits of 
surveillance are well described in the literature and Brink et al (26) report an overall reduction in 
mean antibiotic use when prospective audit is applied in combination with intervention and 
feedback.(39) Essentially, surveillance is a means to audit behavior change. Effective, relevant and 
timely feedback of behaviours to measure change are recommended by Singh et al as one of the 
components on a framework to improve integrated care in infection management.(19) 
Patient and the publics’ role in and contribution to AMS is recognized by the learners. Value is placed 
on how the patient’s perspective can usefully calibrate and widen HCWs views on AMS to improve 
outcomes. A gap exists both in the active engagement of patients in decision-making to ameliorate 
demands for unregulated antibiotics as well as greater awareness of their own infection care. 
Although much is written about engaging patients on IPC and AMS in policies and guidelines, a 
recent scoping review suggests that, current infection-related patient participation measures are 
limited, emphasising the many missed opportunities for patient engagement.(Mbamalu et al, under 
review, (40) (41)  
 
This study has limitations. Even though this MOOC enabled gathering insights about AMS from 
across the world, responses could not be linked to the learners’ specific country as not all indicated 
this information in their comments. Despite that, this platform provides insights from across diverse 
cultural and economic contexts. The findings represent the experiences of individual learners 




This analysis of experiences of AMS in different countries provided insights on unique challenges 
present in different contexts spanning teams and systems considerations. There needs to be greater 
efforts in recognising the role of non-physician health care professionals in AMS as well as seeking 
greater active patient and public involvement. Customising AMS programmes to account for 
contextual drivers such as local leadership structures, and access to antibiotics can facilitate the 
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Table 1: Excerpts from responses on MOOC platform 
ID Quote 
X1 Weekly Friday morning AMS meeting with Clinical microbiologist, Physicians, Pediatricians, IPC Senior, Clinical Pharmacist, intensive care unit staff, nursing 
infection control champions and Nursing Education Department. Strategies include antimicrobial prescription chart, audits and monthly antibiogram 
presentation. 
X2 AMS for regional and remote communities without ID/Microbiology. Delivered via tele health rounds and a phone hot line to an ID doctor or AMS pharmacist. 
Interventions include consulting AMS if intravenous (IV) antibiotics prescribed over 48 hours, IV to oral switch procedures etc. 
X3 Tertiary care hospitals generally have AMS but programs in long-term care or community practice lag. Provinces like Alberta have a provincial AMS. They also 
have the community-based ‘Do Bugs Need Drugs’ program, as does British Columbia which does some great public education and hosts an online dashboard 
display for AMR and antibiotic utilisation data. Ontario has a gold standard AMS scaled-up in hospitals across the province, which began in intensive care units. 
‘Rx Files’ is an academic detailing program from Saskatchewan which supports stewardship decision making through consultations with physicians using the 
nudge method. Some jurisdictions are looking at systems for audit and feedback for prescribers. 
X4 AMS in my country, Nigeria, has been underestimated in the past, only until recently that the Global Action plan to reduce antimicrobial resistance was published 
and became a template which various countries around the world adopted and constitute the national version of the plan.  
AMS is not a term often used in this country, because, not so many even know about it. 
X5 As far as I am aware, there are no stewardship activities happening in my city at any hospitals. Only IPC activities are in practice that too only at large corporate 
hospitals who are forced to implement IPC for accreditation purposes like the Indian NABH (National Accreditation Board for Hospitals).  
Data collection not done expect at certain research institutes. 
X6 Very little is being done or practically there are no existing structures/interventions in my environment to regulate or optimise prescription of antibiotics. 
X7 The AMS committee developed the antibiotics guidelines based on local antibiogram. Every year the committee update the antibiotics guidelines. The application 
of antibiotics guidelines was assessed by doing a small research of the junior doctor and reported to the committee.  
X8 We have empirical treatment and prophylaxis guidelines and an antibiotic prescribing policy which encourages the start smart then focus approach to prescribing 
as well as encouraging use of narrow spectrum antibiotics. 
X9 Antimicrobial resistant microorganisms are increasing in our setting as the people can buy the antibiotics from the pharmaceutical shop without prescription. Our 
hospital has the yearly local antibiogram depending on the culture isolates from microbiology department. All the head of specialist involved in the antimicrobial 
stewardship committee. And the antimicrobial stewardship committee developed the antibiotics guidelines based on local antibiogram. Every year the 
committee update the antibiotics guidelines. The application of antibiotics guidelines was assessed by doing a small research of the junior doctor and reported to 
the committee. We don't have electronic prescription systems and clinical decision support systems. The committee tried to check the antibiotics utilisation by 
global point prevalence surveys even though we don't have a clinical pharmacist. The senior nurse is involved in the infections control committee. And continuing 
monitoring and education is held monthly in the hospital to improve the knowledge and current trend of antibiotics, outbreak tracing and to solve some problem. 
With the help of all department participating, we can make a system to encourage the judicious use of antibiotics. 
X10 At the setting that I work, there is an AMS committee. There is an antibiotic policy which is under utilised. There are physicians who aspire to rationalise antibiotic 
use. Still unable to implement it due to multiple factors. I would like to see a change in attitude towards prescription of antimicrobials. 




between policy making and implementation of guidelines should therefore be bridged by the motivated healthcare team involving the nurses and doctors and 
pharmacists. 
X12 There are no strict measures as regard the prescription and usage of antibiotics in my country. there are only unimplemented policies. Nurses and pharmacist 
actively get involved in the prescription of antibiotics. I look forward to a setting where everything will be orderly. With me and other people taking this course. 
X13 There are no clear policies or guidelines regarding antibiotics prescribing or purchasing and doctors recommend the antibiotics as a dose to every person for 
effective results and get a lot of commission by prescribing the antibiotics. 
X14 Pharmacist have the role of monitoring of the use of antibiotics and biologist the role of monitoring of antimicrobial resistance. Data provide by pharmacist and 
biologist are included in a national Survey about consumption of antibiotic and antimicrobial resistance. 
X15 Pharmacists validate each prescription of antibiotics and advise on the indication of restricted antibiotics. 
X16 Pharmacists do play a key role in AMS because they are one of the gatekeepers in terms of community's antimicrobial access. 
X17 Pharmaceutical staff often lack training and knowledge on antimicrobial drugs and AMR which exacerbates the issue of over-prescribing. 
X18 Nurses and pharmacists have a limited role, which does not include the authority to make decisions regarding the person's intake of antibiotics, but only for the 
nurses to administer it and for the pharmacist to provide it. 
X19 Nurses and pharmacists have a role to play which is basically to educate the patient.  
X20 Pharmacist are trying hard to educate the healthcare professionals and patients that misuse of antibiotics will develop resistance against bacteria. 
X21 The role of nurses is not explicit. They are expected to warn of signs of infection, response to treatment, to obtain the relevant samples in a timely manner. But it 
has not been reflected in any document or policy. In fact, the infection control team seems to also fight against this circumstance to get the nurses involved. 
X22 The nurse has a role to educate patient about the use of antibiotics, they actively remind the patient to take their medication (in the hospital). 
X23 People laugh at the statistics that by 2050, 10 million people will be dying every year... And I think that's my biggest risk right now, that people still don't take 
AMR as seriously as they should. 
The problem is not close enough to them, personally, for most people to engage with it properly.  
Also, there is a lack of understanding that each of us is what - 10% mammalian DNA and 90% microbial? Every creature has its own microbiome, which differs 
according to site. At each site it serves a defensive purpose. Disrupt it, and new problems emerge. Maybe a new perspective is required, that each of us must care 
for our microbial cells as well as the mammalian ones of each organ system. 
X24 No clear policies or guidelines regarding antibiotics prescribing or purchasing and doctors recommend the antibiotics as a dose to every person for effective 
results and get a lot of commission by prescribing on the antibiotics. 
X25 There is a national action plan to combat AMR, yet, the campaign is at zero level 
X26 Some countries in the region do have guidelines but it's the implementation where the problem lies. Most of these guidelines are focused on public health and 
not much on animal health 
X27 Several policies and guidelines do exist, but they play little role in informing antibiotics prescription by clinicians both in rural and urban settings. The gap 
between policy making and implementation of guidelines should therefore be bridged by the motivated healthcare team involving the nurses and doctors and 
pharmacists. 
X28 Many of the challenges in Uganda are not more different than in other countries: lack of leadership, the lack of expertise at health centres and problems with 
tracking and reporting. 
X29 A lot of practices described are familiar. Surgeons like to outsource antibiotic prescribing to others like internal medicine specialists, anaesthesiologists, or IDs. 








figure out which antibiotic to give, not ours. 
X30 There are antibiotic stewardship rounds in surgical departments, but internal medicine etc are still not on-board with this 
X31 Healthcare associated infection data are poorly captured. 
Improvements needed in communication and understanding of differences in team dynamics and AMS in different clinical areas 
X32 At present, reports from the AMS committee for our hospital is not readily available. As mentioned by the Uganda AMS scientists, we cannot work on AMR or 
AMS without data. I now have the buy-in from my hospital's infection control team to work on prevention and surveillance on MRSA, and will try to get to know 
the AMS team of my hospital better to get the buy-in to work together. 
X33 Economic analysis has not been done in my setting hence impact not realised. Also, inconsistent antibiotic ward rounds noted.  
X34 I think, patients view or experiences are important in carrying on with a successful intervention or modifying it.  
Patients perspective can add to the knowledge of prescribing or a treatment plan as the one going through the experience is the patient and not the healthcare 
professional. 
X35 End-users of AM drugs are a fundamental part of the whole AMS process so yes, their input must be included wherever possible, as part of understanding the 
context in which interventions are to operate. 
I think that this would alter the perspective and focus of some decisions. Policies and guidelines are all very well but they have to have the desired effect, so it 
seems relevant to assess key performance indicators and then work backwards using social science methods to identify which changes can be made which could 
have the biggest positive effect. 
X36 The answer for using more patient's knowledge and experience in my daily practise is yes, I would. Beside good medical records of each patients, it’s also needed 
to explore more about how much they understand their issue/case so we can fill the gap of the missing essential information for them. 
X37 Patient involved would be vital for designing and reviewing interventions and materials that are directly targeted at patients and citizens. Patient involvement in 
wider interventions could also throw up useful questions that health professionals haven't considered (e.g. communication, risks, etc). This information could be 
gathered at intervention design meetings, through consultation, and direct discussions with expert patients. 
X38 My local GP practice has been very ahead of its time when it comes to AMR and has put in place strategies to avoid over prescription of them. I have heard of 
stories in the past of patients requesting antibiotics and sometimes even requesting them 'just in case' they're infection became worsened, sometimes people 
would request them to take abroad if they were prone to some infection. Therefore, in the waiting room there are posters placed to educate people of the 
potential risks to unnecessary prescription of antibiotics. The people in my community have started to understand the issue with AMR. The GPs now avoid their 




Box 1: AMS activities reported by learners on the MOOC*   
 
● Weekly academic presentations by microbiologist, physicians, clinical pharmacists, or 
academic guests of treatment guidelines. 
● Weekly morning AMS meeting with clinical microbiologist, physicians, paediatricians, IPC 
nurse, clinical pharmacist, Intensive care unit staff, nursing infection control champions 
and nursing education department. AMS strategies include a dedicated antimicrobial 
prescription chart, audits and monthly antibiogram reports. 
● Weekly AMS rounds with pharmacist, microbiologist, IPC and concerned clinicians. 
● Antibiotic rounds at certain wards (mostly surgical) and antibiotic consultation by ID 
 specialist available at all times. 
● Advising prescribing physician in the use of antibiotics by ID specialists and focus on 
intensive care and other specialties where they have identified opportunity for 
improvement. 
● Collaborative policy development involving pharmacists, microbiologists, and clinicians. 
● AMS delivered via tele health rounds and phone hot line by an ID doctor or AMS 
Pharmacist to regional and remote communities without ID specialist or Microbiologist. 
*These report on responses by the learners and may be limited in detail to provide insight into 


















Table 2: Reported roles and challenges of pharmacists and nurses in AMS across sectors* 
 
*These report on responses by the learners and may be limited in detail to provide insight into specific contexts.  
 Profession 
 Pharmacists Nurses 
Roles   
● Prescribing and optimising antibiotic use. 
• Educate and advice HCW about the rational use of 
antibiotics and AMS. 
● Collect data on AMS performance indicators and 
provide feedback to stakeholders. Monitor antibiotic 
use and provide data on antibiotic consumption.  
● Monitor antibiotic use and provide data on antibiotic 
consumption.  
● Act as gatekeepers for antimicrobial access in the 
community. 
● Review and validate each prescription of antibiotics 
and advise on the appropriate use of restricted 
antibiotics. 
● Authorise use of restricted antibiotic for hospital 
inpatients. Educate healthcare professionals and 
patients on the impact of antibiotic misuse on 
resistance. 
● Facilitate communication between a doctor and a 
patient. 
● Lead patient education around AMR/AMS. Review 
indications for prescribed medicines with prescribers 
(weekly review). 
 
• Administer antibiotics. 
 
• Prescribe antibiotics in contexts where it is permitted. 
 
• Monitor patients and respond to signs of infection.  
 
• Educate patient about the use of antibiotics and 
ensure that prescribed courses are completed by 
patients in hospital. 
 
Challenges ● Lack of training and knowledge on antimicrobials and 
AMR which exacerbates the issue of over-prescribing. 
● Perception that pharmacists have a limited role in 
antibiotic decision making as their role is restricted to 
dispensing antibiotics. 
● Providing antibiotics without a prescription to 
patients who are unable to see a doctor.  
 
● Perception that nurse’s role in AMS is limited to antibiotic 
administration.  
● Perception that nursing does not have a role in AMS. 
● Despite nursing unit managers and ward champions 
attending AMS rounds, their roles are not defined.  
● Apart from IPC nurses, the general nursing body are not 
involved in AMS. 
● Role of nursing in AMS (generally) is not defined in hospital 
policy and guidelines. 
● The role of nurses is not explicit. They are expected to warn 
of signs of infection, response to treatment, to obtain the 
relevant samples in a timely manner. These have not been 




Box 2: Recommendations for improvement 
 
Governance, policies, and guidelines 
● Improved leadership and support from governments and local authorities to provide contextually fit guidelines and policies that 
include regional and current data, not just theoretical suggestions. 
● Regulations to restrict sale of antibiotics without a prescription in pharmacies and from street vendors thereby ameliorating 
irrational use of antibiotics. 
● Bridge the gap between policy making and implementation of guidelines by involving motivated HCWs which include nurses, 
doctors and pharmacists in the policy design and roll out. 
● Streamline government regulations and support to ensure dedicated prescribing guidelines to facilitate optimum decision 
making.  
AMS across all health sectors 
● Improve engagement strategies to optimise AMS across all health sectors. 
Diagnostics to guide targeted antibiotic prescription 
● Patients to undergo diagnostic tests for microbial sensitivity before being prescribed an antibiotic drug to facilitate subsequent. 
tailoring and optimisation of antibiotic as appropriate. 
Teamwork and communication /Team practices/ routines 
● Improve communication and understanding of differences in team dynamics and AMS in different clinical areas. 
● Daily antibiotic rounds with the pharmacist and clinical infection specialist. 
Roles/ responsibilities/ ownership 
● Establish teams in each ward to monitor and manage antibiotic use. 
● Expand AMS teams to include members from other specialties such as medical and surgical to ensure optimal antimicrobial use 
across patient pathway. 
● Select champions from the respective fields. Those persons will be responsible in spreading the information among their 
colleagues and when they will limit antibiotics prescription themselves others will see and learn. 
● Involve surgeons in AMS team to improve patient outcomes post-operatively. 
● Increase involvement of pharmacists and nurses in AMS. 
● Participation in AMS to be a shared goal by all HCWs and staff in the hospital. 
● Clearly defined AMS role of all nurses’ categories (as defined in hospital policy) 
● Develop or enhance independent prescribing by nurses to support management of specific infections, especially in remote 
settings and/or where it may be advantageous to reduce physician workload (in primary or secondary care). 
Approaches to tackling change:  
● Develop AMS to consider context and differences between departments, and tailored to support the specific requirements of 
each e.g. individualism in surgical teams 
● Consider local context when looking to bring about a change in behaviour. 
Surveillance to inform practice 
● Provide a system with evidence-based prescribing, strong data collection system and responsible use of antibiotics 




● Utilise outcomes data to inform different antibiotic regimens 
● Utilise surveillance data on antibiotic consumption and infections such as bacteraemia. 
Patient and public Awareness AMR and education 
● Improve population awareness of AMR and how they can self-manage certain infections without antibiotics or improve patient 
adherence to antibiotic courses when prescribed. 
● Co-ordinate approach and education campaigns across human, environmental, and veterinary (including vets and farmers) 
sectors (OneHealth). 
● Use public health campaign to educate the public on how to improve the gut microbiome and support better health overall. 
● Improve public and patient education on antibiotic use to enable engagement with the practitioner when they are prescribed 
antibiotics. 
● Using patient’s personal experiences could be used as relatable examples for other patients and public on the challenges of 
AMR. 
● Improve patients’ trust in the treatment (antibiotics) prescribed to them   
● Age-appropriate education of the general population at all ages and stages to improve awareness of AMS issues using 
innovative and creative interventions such as ‘YouTube’ animations. 
● Intentional educational outreach especially to ‘underprivileged’ communities  
● Targeted student education: Increase awareness on AMR and inform them on policies or legislation tackling the issue in their 
countries country, and believe that antibiotics are overused in many situations, particularly for agricultural productivity. 
 
 
   
 
